Market Tracker

08/28 6:01pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.50
Delayed Data
As of Aug 28
 +0.07 / +0.67%
Today’s Change
6.38
Today|||52-Week Range
13.84
-7.08%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close10.43
Today’s open10.31
Day’s range10.31 - 11.00
Volume2,617,481
Average volume (3 months)1,329,368
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-40.89%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...+0.32+3.69%
CLLSCellectis SA+0.51+1.56%
DVAXDynavax Technologies...+1.31+4.60%
RGENRepligen Corp-0.09-0.26%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts